FDA action counts
| Total FDA actions | 15 |
|---|---|
| Warning letters | 0 |
| Recalls | 15 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | June 10, 2026 |
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Becton Dickinson & Company has 13 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Enforcement history
On 2026-05-27, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "high" severity in Argus HQ's classification: Becton, Dickinson and Company — Class II recall: Swan-Ganz Jr Catheter, Models: SGPT54, SGPT64P, SGPT755P An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-05-27, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "high" severity in Argus HQ's classification: Becton, Dickinson and Company — Class II recall: Swan-Ganz Pacing Catheter, Models: D200F7; An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-05-27, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "high" severity in Argus HQ's classification: Becton, Dickinson and Company — Class II recall: Swan-Ganz Catheter, Models: 131F7/131F7P, 131F7J, 141F7, 151F7, 834F75, 096F6/09… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in., BD¿Quincke Needle 22 G x… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Quincke Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… An.
Frequently asked questions
- What is the most recent FDA action against Becton Dickinson & Company?
- The most recent FDA event Argus HQ has on file for Becton Dickinson & Company is dated 2026-06-10, with a severity rating of "critical" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- Does Argus HQ track new FDA actions for Becton Dickinson & Company automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Becton Dickinson & Company is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Becton Dickinson & Company?
- 15 total: 0 warning letters, 15 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Becton Dickinson & Company?
- June 10, 2026. Argus HQ ingests new FDA enforcement records daily.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Quincke Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 24 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Quincke Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL,… →
- Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in., BD¿Quincke Needle 22 G x… →
Compare with
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Regulatory Record: Becton Dickinson & Company. Digital Empire LLC. Retrieved from https://argushq.ai/company/becton-dickinson-and
"Regulatory Record: Becton Dickinson & Company." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/becton-dickinson-and.
Argus HQ Research. "Regulatory Record: Becton Dickinson & Company." Digital Empire LLC. Accessed July 14, 2026. https://argushq.ai/company/becton-dickinson-and.
@misc{argushq_argushq_ai_company_becton_dickinson_and_2026,
title = {Regulatory Record: Becton Dickinson & Company},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/company/becton-dickinson-and},
note = {Accessed: July 14, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗